etilefrine has been researched along with Hemolysis in 1 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ischemic priapism is a common but underrecognized morbidity affecting about 33% of adult men with sickle cell disease (SCD)." | 2.82 | Epidemiology and treatment of priapism in sickle cell disease. ( Burnett, AL; DeBaun, MR; Idris, IM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Idris, IM | 2 |
| Burnett, AL | 2 |
| DeBaun, MR | 2 |
1 review available for etilefrine and Hemolysis
| Article | Year |
|---|---|
Epidemiology and treatment of priapism in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Clinical Trials, Phase II as Topic; Etilefrine; Hemolysis; Humans; Male; | 2022 |
Epidemiology and treatment of priapism in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Clinical Trials, Phase II as Topic; Etilefrine; Hemolysis; Humans; Male; | 2022 |
Epidemiology and treatment of priapism in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Clinical Trials, Phase II as Topic; Etilefrine; Hemolysis; Humans; Male; | 2022 |
Epidemiology and treatment of priapism in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Clinical Trials, Phase II as Topic; Etilefrine; Hemolysis; Humans; Male; | 2022 |